In larger sample sets of SCLC and NSCLC as well as lung cancer metastases, one could narrow the time point when ZAR1 becomes hypermethylated and inactivated during lung carcinogenesis. The gene discussed is ZAR1; the disease is non-small cell lung carcinoma.